Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.

Latest updates to the Tepotinib Phase II Clinical Trial page
- Check8 days agoChange DetectedShows a new 'Show glossary' option and minor typographic updates in the Study Record Dates area, including capitalization changes in 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new 'Revision: v3.4.0' label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedThe Study Record Dates section now displays 'Last Update Posted' as a standalone item, replacing the previous 'Last Update Posted (Estimated)' label.SummaryDifference0.0%

- Check22 days agoChange DetectedFooter revision updated to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Study Record Dates section now shows 'Last Update Posted (Estimated)' instead of 'Last Update Posted'. This is a metadata clarification that does not alter the study details or how users interact with the page.SummaryDifference0.0%

- Check44 days agoChange DetectedEU CTIS number 2024-512003-39-00 was added and recruitment locations were expanded to 176 sites across the US and Europe. The page revision notes version v3.3.3 and updates to location details.SummaryDifference1%

- Check73 days agoChange DetectedAdded clarifying text about the Publications section: some publications are provided voluntarily and relate to the results, while others are automatically filled from PubMed. Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.